TATVA CHINTAN PHARMA CHEM Financial Statement Analysis
|
||
The Revenues of TATVA CHINTAN PHARMA CHEM have increased by 44.38% YoY .
The Earnings Per Share (EPS) of TATVA CHINTAN PHARMA CHEM has decreased by -52.55 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
TATVA CHINTAN PHARMA CHEM Last 5 Annual Financial Results
[BOM: 543321|NSE : TATVA]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹434 Cr | ₹300 Cr | ₹263 Cr | ₹206 Cr | ₹135,460,463 Cr |
Expenses | ₹325 Cr | ₹234 Cr | ₹208 Cr | ₹172 Cr | ₹113,968,627 Cr |
Operating Profit (Excl OI) | ₹109 Cr | ₹67 Cr | ₹55 Cr | ₹34 Cr | ₹21,491,836 Cr |
Other Income | ₹9.02 Cr | ₹5.20 Cr | ₹1.38 Cr | ₹0.49 Cr | ₹4,782,254 Cr |
Interest | ₹5.23 Cr | ₹4.45 Cr | ₹4.27 Cr | ₹3.95 Cr | ₹3,157,462 Cr |
Depreciation | ₹8.18 Cr | ₹6.73 Cr | ₹4.79 Cr | ₹4.02 Cr | ₹3,583,616 Cr |
Profit Before Tax | ₹104 Cr | ₹61 Cr | ₹48 Cr | ₹27 Cr | ₹19,510,692 Cr |
Profit After Tax | ₹96 Cr | ₹52 Cr | ₹38 Cr | ₹21 Cr | ₹12,999,650 Cr |
Consolidated Net Profit | ₹96 Cr | ₹52 Cr | ₹38 Cr | ₹21 Cr | ₹12,999,650 Cr |
Earnings Per Share (Rs) | ₹20.52 | ₹43.25 | ₹26.02 | ₹47.03 | ₹25.57 |
PAT Margin (%) | 10.73 | 22.10 | 17.40 | 14.36 | 9.96 |
ROE(%) | 9.21 | 30.01 | 36.85 | 38.29 | 28.95 |
ROCE(%) | 8.35 | 25.75 | 28.04 | 28.40 | 22.78 |
Total Debt/Equity(x) | 0.33 | 0.25 | 0.54 | 0.77 | 0.97 |
Key Financials |
||
Market Cap | : | ₹ 2,848.7 Cr |
Revenue (TTM) | : | ₹ 419.8 Cr |
Net Profit(TTM) | : | ₹ 37.7 Cr |
EPS (TTM) | : | ₹ 16.1 |
P/E (TTM) | : | 75.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
TATVA CHINTAN PHARMA CHEM | -3.2% | -9.5% | -32.7% |
PIDILITE INDUSTRIES | 4% | 9.7% | 25.7% |
SOLAR INDUSTRIES INDIA | 7.9% | 35.1% | 139.9% |
SRF | 6.1% | 8.2% | 8.6% |
GUJARAT FLUOROCHEMICALS | -0.8% | -13% | 0.9% |
DEEPAK NITRITE | 1.2% | -7.2% | 20.3% |
TATA CHEMICALS | -3.1% | 11.2% | 9.8% |
GODREJ INDUSTRIES | 2.6% | -5.7% | 83.1% |
AARTI INDUSTRIES | 3.2% | -2.6% | 25.8% |
TATVA CHINTAN PHARMA CHEM Revenues
[BOM: 543321|NSE : TATVA]
Y-o-Y | 44.38 % |
5 Yr CAGR | -95.77 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹434 Cr | 44.38 | |
Mar2022 | ₹300 Cr | 14.10 | |
Mar2021 | ₹263 Cr | 27.60 | |
Mar2020 | ₹206 Cr | -100.00 | |
Mar2019 | ₹135,460,463 Cr | - |
TATVA CHINTAN PHARMA CHEM Operating Profit
[BOM: 543321|NSE : TATVA]
Y-o-Y | 62.75 % |
5 Yr CAGR | -95.26 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹109 Cr | 62.75 | |
Mar2022 | ₹67 Cr | 20.63 | |
Mar2021 | ₹55 Cr | 62.03 | |
Mar2020 | ₹34 Cr | -100.00 | |
Mar2019 | ₹21,491,836 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 12.70 % |
5 Yr CAGR | 12.05 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 25.02% | 12.70 | |
Mar2022 | 22.2% | 5.71 | |
Mar2021 | 21% | 26.96 | |
Mar2020 | 16.54% | 4.22 | |
Mar2019 | 15.87% | - |
TATVA CHINTAN PHARMA CHEM Profit After Tax
[BOM: 543321|NSE : TATVA]
Y-o-Y | 83.45 % |
5 Yr CAGR | -94.79 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹96 Cr | 83.45 | |
Mar2022 | ₹52 Cr | 38.30 | |
Mar2021 | ₹38 Cr | 83.95 | |
Mar2020 | ₹21 Cr | -100.00 | |
Mar2019 | ₹12,999,650 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -51.45 % |
5 Yr CAGR | 1.88 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 10.73 % | -51.45 | |
Mar2022 | 22.1 % | 27.01 | |
Mar2021 | 17.4 % | 21.17 | |
Mar2020 | 14.36 % | 44.18 | |
Mar2019 | 9.96 % | - |
TATVA CHINTAN PHARMA CHEM Earnings Per Share (EPS)
[BOM: 543321|NSE : TATVA]
Y-o-Y | -52.55 % |
5 Yr CAGR | -5.35 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹21 | -52.55 | |
Mar2022 | ₹43 | 66.22 | |
Mar2021 | ₹26 | -44.67 | |
Mar2020 | ₹47 | 83.93 | |
Mar2019 | ₹26 | - |
TATVA CHINTAN PHARMA CHEM Return on Capital Employed (ROCE)
[BOM: 543321|NSE : TATVA]
Y-o-Y | -67.57 % |
5 Yr CAGR | -22.19 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 8.35% | -67.57 | |
Mar2022 | 25.75% | -8.17 | |
Mar2021 | 28.04% | -1.27 | |
Mar2020 | 28.4% | 24.67 | |
Mar2019 | 22.78% | - |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
Current Share Price | : | ₹1,217.4 |
Current MarketCap | : | ₹ 2,848.7 Cr |
Updated EOD on | : | Apr 19,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TATVA CHINTAN PHARMA CHEM | -3.2% |
-9.5% |
-32.7% |
SENSEX | -2.6% |
-0% |
21% |
TATVA CHINTAN PHARMA CHEM related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | -1.6% | 8.4% | 61.4% |
S&P BSE MIDSMALLCAP | -2.1% | 6.3% | 61.6% |
S&P BSE BASIC MATERIALS | -2.2% | 7.9% | 36.7% |
S&P BSE ALLCAP | -2.5% | 2.7% | 37.3% |
You may also like the below Video Courses
FAQ about TATVA CHINTAN PHARMA CHEM Financials
How the annual revenues of TATVA CHINTAN PHARMA CHEM have changed ?
The Revenues of TATVA CHINTAN PHARMA CHEM have increased by 44.38% YoY .
How the Earnings per Share (EPS) of TATVA CHINTAN PHARMA CHEM have changed?
The Earnings Per Share (EPS) of TATVA CHINTAN PHARMA CHEM has decreased by -52.55 % YoY .
PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs